In addition, hepatic 5-HTR2A and 5-HTR2B signaling might contribute to hepatic fibroblast growth factor-21 (FGF21) production and the pathophysiological mechanisms of type 2 diabetes (T2D) and metabolic dysfunction-associated fatty liver disease (MAFLD) [56]. This evidence concerns the gene FGF21 and type 2 diabetes mellitus.